| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |